Item Type | Name |
Academic Article
|
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.
|
Academic Article
|
A young woman with a small ER-positive breast cancer, a micrometastatic axillary lymph node, and an intermediate oncotype DX recurrence score.
|
Academic Article
|
Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment.
|
Academic Article
|
Immunomodulatory therapy in multiple sclerosis and breast cancer risk: a case report and literature review.
|
Academic Article
|
A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer.
|
Academic Article
|
Pregnancy and breast cancer: when they collide.
|
Academic Article
|
Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy.
|
Academic Article
|
Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.
|
Academic Article
|
Early-stage BRCA2-linked breast cancer diagnosed in the first trimester of pregnancy associated with a hypercoagulable state.
|
Academic Article
|
BRCA in breast cancer: from risk assessment to therapeutic prediction.
|
Academic Article
|
Diagnosis of invasive lobular carcinoma in a young woman presenting with pleomorphic lobular carcinoma in situ on core biopsy.
|
Academic Article
|
The era of high-dose chemotherapy for breast cancer: revisiting a troubled quest.
|
Academic Article
|
Genomic signatures of pregnancy-associated breast cancer epithelia and stroma and their regulation by estrogens and progesterone.
|
Academic Article
|
A postmenopausal woman with early-stage breast cancer and borderline hormone-receptor staining.
|
Academic Article
|
A woman with primary breast cancer and a solitary sternal metastasis.
|
Academic Article
|
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.
|
Academic Article
|
Role of fulvestrant in sequential hormonal therapy for advanced, hormone receptor-positive breast cancer in postmenopausal women.
|
Academic Article
|
Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance.
|
Academic Article
|
Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor.
|
Academic Article
|
Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium.
|
Academic Article
|
Microenvironment of the involuting mammary gland mediates mammary cancer progression.
|
Academic Article
|
Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.
|
Academic Article
|
Hepatic complications of breast cancer.
|
Academic Article
|
Fulvestrant: a unique antiendocrine agent for estrogen-sensitive breast cancer.
|
Academic Article
|
Emerging targets for the prevention of pregnancy-associated breast cancer.
|
Academic Article
|
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.
|
Academic Article
|
Pregnancy-associated breast cancer: an entity needing refinement of the definition.
|
Academic Article
|
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.
|
Academic Article
|
Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer.
|
Concept
|
Breast Neoplasms, Male
|
Concept
|
Breast Neoplasms
|
Academic Article
|
Body image in recently diagnosed young women with early breast cancer.
|
Academic Article
|
Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy.
|
Academic Article
|
Physiological COX-2 expression in breast epithelium associates with COX-2 levels in ductal carcinoma in situ and invasive breast cancer in young women.
|
Academic Article
|
Prospective study of fertility concerns and preservation strategies in young women with breast cancer.
|
Academic Article
|
Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling.
|
Academic Article
|
Treatment-related amenorrhea and sexual functioning in young breast cancer survivors.
|
Academic Article
|
Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.
|
Academic Article
|
Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer.
|
Academic Article
|
Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema.
|
Academic Article
|
Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.
|
Academic Article
|
Management of young breast cancer patients with de novo genetic mutations.
|
Academic Article
|
Developmental windows of breast cancer risk provide opportunities for targeted chemoprevention.
|
Academic Article
|
Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
|
Academic Article
|
Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression.
|
Academic Article
|
Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American Women.
|
Academic Article
|
Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.
|
Academic Article
|
Multiple Hepatic Lesions in a Patient With a History of DCIS.
|
Academic Article
|
Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
|
Academic Article
|
Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
|
Academic Article
|
Partner support and anxiety in young women with breast cancer.
|
Academic Article
|
Management of the patient with postpartum breast cancer.
|
Academic Article
|
21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile.
|
Academic Article
|
Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism.
|
Academic Article
|
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.
|
Academic Article
|
Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR.
|
Academic Article
|
A 40-Year-Old Woman With a New Triple-Negative Breast Mass, Shown on Biopsy to Be Metaplastic Carcinoma.
|
Academic Article
|
Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer.
|
Academic Article
|
Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies.
|
Academic Article
|
Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2+-Advanced Solid Tumors, with an Expansion Cohort in HER2+ Metastatic Breast Cancer (MBC).
|
Academic Article
|
The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis.
|
Academic Article
|
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
|
Academic Article
|
The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?
|
Grant
|
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
|
Academic Article
|
Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium.
|
Academic Article
|
Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
|
Academic Article
|
Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study.
|
Academic Article
|
A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer.
|
Academic Article
|
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.
|
Academic Article
|
Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 Inhibition.
|
Academic Article
|
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.
|
Academic Article
|
A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma.
|
Academic Article
|
Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer.
|
Academic Article
|
Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer.
|
Academic Article
|
Innovations in Personalized and Targeted Therapies for Breast Cancer.
|
Academic Article
|
Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.
|
Academic Article
|
Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
|
Academic Article
|
Identifying distinct trajectories of change in young breast cancer survivors' sexual functioning.
|
Concept
|
Triple Negative Breast Neoplasms
|
Academic Article
|
Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
|
Academic Article
|
Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients.
|
Academic Article
|
Employment trends in young women following a breast cancer diagnosis.
|
Academic Article
|
PD-1 Blockade During Post-partum Involution Reactivates the Anti-tumor Response and Reduces Lymphatic Vessel Density.
|
Academic Article
|
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
|
Academic Article
|
Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer.
|
Academic Article
|
Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer.
|
Academic Article
|
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
|
Academic Article
|
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
|
Academic Article
|
Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival.
|
Academic Article
|
Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?
|
Academic Article
|
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial).
|
Academic Article
|
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
|
Academic Article
|
Association of Breast Cancer Surgery With Quality of Life and Psychosocial Well-being in Young Breast Cancer Survivors.
|
Academic Article
|
Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients.
|
Academic Article
|
Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers.
|
Academic Article
|
Partners of young breast cancer survivors: a cross-sectional evaluation of psychosocial concerns, coping, and mental health.
|
Academic Article
|
Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center.
|
Academic Article
|
Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer.
|
Academic Article
|
S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue.
|
Academic Article
|
Characterization of weaning-induced breast involution in women: implications for young women's breast cancer.
|
Academic Article
|
Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer.
|
Academic Article
|
Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer.
|
Academic Article
|
Extracellular vesicles from young women's breast cancer patients drive increased invasion of non-malignant cells via the Focal Adhesion Kinase pathway: a proteomic approach.
|
Academic Article
|
Tumor phenotype and concordance in synchronous bilateral breast cancer in young women.
|
Academic Article
|
Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort Study.
|
Academic Article
|
New Persistent Opioid and Benzodiazepine Use After Curative-Intent Treatment in Patients With Breast Cancer.
|
Academic Article
|
Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval.
|
Academic Article
|
Postpartum breast cancer: mechanisms underlying its worse prognosis, treatment implications, and fertility preservation.
|
Academic Article
|
Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials.
|
Academic Article
|
Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial.
|
Academic Article
|
Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors.
|
Academic Article
|
Arm Morbidity After Local Therapy for Young Breast Cancer Patients.
|
Academic Article
|
The definition of pregnancy-associated breast cancer is outdated and should no longer be used.
|
Academic Article
|
Vitamin D as a Potential Preventive Agent For Young Women's Breast Cancer.
|
Academic Article
|
Trajectories of fear of cancer recurrence in young breast cancer survivors.
|
Academic Article
|
Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer.
|
Academic Article
|
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1?+ tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.
|
Academic Article
|
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy.
|
Academic Article
|
Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer.
|
Academic Article
|
Options for Endocrine-Refractory, Hormone Receptor-Positive Breast Cancer: Which Target and When?
|
Academic Article
|
Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer.
|
Academic Article
|
Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes.
|
Academic Article
|
Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2.
|
Academic Article
|
The Expanded Role of Ovarian Suppression for Young Women's Breast Cancer: An Era of Patient-Tailored Decision Making.
|
Academic Article
|
Mammary collagen is under reproductive control with implications for breast cancer.
|
Academic Article
|
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis.
|
Academic Article
|
Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer.
|
Academic Article
|
Psychosocial issues and quality of life of parenting partners of young women with breast cancer.
|
Academic Article
|
PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
|
Academic Article
|
Overall survival is the lowest among young women with postpartum breast cancer.
|
Academic Article
|
Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors.
|
Academic Article
|
Coping strategies and anxiety in young breast cancer survivors.
|
Academic Article
|
The effects of resistance exercise on appetite sensations, appetite related hormones and energy intake in hormone receptor-positive breast cancer survivors.
|
Academic Article
|
Impacts of breast cancer and chemotherapy on gut microbiome, cognitive functioning, and mood relative to healthy controls.
|
Academic Article
|
Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial.
|
Academic Article
|
Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer.
|
Academic Article
|
What Dobbs Means for Patients with Breast Cancer.
|
Academic Article
|
Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ.
|
Academic Article
|
Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers.
|
Academic Article
|
Corrigendum to "Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis": [Annals of Oncology 33 (2022) 321-329].
|
Academic Article
|
Tumor-restrictive type III collagen in the breast cancer microenvironment: prognostic and therapeutic implications.
|
Academic Article
|
Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors.
|
Academic Article
|
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
|
Academic Article
|
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
|
Academic Article
|
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
|
Academic Article
|
Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab.
|
Academic Article
|
Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors.
|
Academic Article
|
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression.
|
Grant
|
A SIM2s/SEMA7A Switch Drives ER+ Breast Cancer Progression
|